Prevail™ Paclitaxel Coated PTCA Balloon Catheter

Understand why the Medtronic paclitaxel coated PTCA balloon is an effective treatment option for in-stent restenosis, de novo lesions, and small vessels. 

Download brochure

Overview

Right Case Right Time Prevail™

Watch an animation to see why Prevail™ drug-coated balloon offers the performance you want for treating complex lesions during percutaneous coronary interventions.1 

Right Case Right Time Prevail™

Prevail™ drug-coated balloon offers the performance you want for treating complex lesions during percutaneous coronary interventions.1 

#

Product details

Device performance

Superior Deliverability2

PowerTrac technology and hydrophilic coating enable superior deliverability

  1. Ultra-slim balloon material for optimised folds
  2. Low profile marker bands
  3. Tapered tip
  4. Lower crossing profile
  5. PowerTrac™ technology and hydrophilic coating
  6. Compatible with 5 F guide catheter
#

Prevail™ DCB Is Twice As Pushable As IN.PACT™ FALCON DCB

FPO

Drug coating

FPO

Proven  Freepac Coating5

FreePac coating combines two proven components that work together:

  • Paclitaxel — potent antirestenotic drug that remains within tissue throughout the healing process6
  • Urea — biocompatible excipient that enables rapid and reliable drug transfer within 30–60 seconds1,3

Clinical Evidence

Building Clinical Evidence

The PREVAIL™ Study adds to the clinical legacy of the IN.PACT™ Falcon Clinical Program. 

IN.Pact™ Falcon Clinical Program

  • IN.PACT™ Falcon DCB with FreePac coating
  • 10 trials
  • > 1,400 patients

Excellent Results with Prevail™ Study‡5

  • Includes complex lesions
  • 54.7% ISR
  • 75% small vessel in de novo lesions

#
#

Ordering Information

  Balloon Length (mm)
Balloon Diameter (mm) 10 15 20 25 30
2.0 PRV020010RX  PRV020015RX PRV020020RX   PRV020025RX  PRV020030RX
2.25 PRV022510RX  PRV022515RX   PRV022520RX PRV022525RX  — 
2.50  PRV025010RX  PRV025015RX  PRV025020RX  PRV025025RX  PRV025030RX
2.75  PRV027510RX  PRV027515RX  PRV027520RX  PRV027525RX  —
3.0  PRV030010RX  PRV030015RX  PRV030020RX  PRV030025RX PRV030030RX 
3.5  PRV035010RX  PRV035015RX  PRV035020RX  PRV035025RX  PRV035030RX
4.0  PRV040010RX  PRV040015RX PRV040020RX  PRV040025RX   PRV040030RX

Downloads

Additional resources

Request more information

CONTACT US
*

™Third-party brands are trademarks of their respective owners.

99% improved push force compared to IN.PACT™ Falcon DCB.

 IN.PACT™ Falcon DCB and Prevail™ DCB use the same FreePac™ coating. PREVAIL Study did not have powered endpoints.

References

1

Prevail Instructions for Use.

2

Compared with IN.PACT Falcon DCB, SeQuent®* Please NEO DCB*, Agent™* DCB, and MagicTouch™* DCB. Deliverability defined as pushability. Based on bench test data, 2020. Bench test data may not be indicative of clinical performance.

3

Barrett BJ. Contrast nephrotoxicity. J Am Soc Nephrol. August 1994;5(2):125-37. 

4

Latib A, et al. PREVAIL Study 12-month results. Results presented at PCR 2020.

5

Virmani R. Arterial wall response to drug-coated balloons. Confluence. September 2016;13:15-19.

6

Cremers B, Clever Y, Schaffner S, et al. Treatment of coronary in-stent restenosis with a novel paclitaxel urea coated balloon. Minerva Cardioangiol. October 2010;58(5):583-8.